|
|
E Bassenge, N Fink, M Skatchkov, B Fink
J Clin Invest. 1998;
102(1):67
doi:10.1172/JCI977
Abstract |
Full text
| PDF

E
nhanced formation of superoxide radicals has been proposed to play a major role in the development of nitrate tolerance in humans. We tested the effects of vitamin C (Vit-C) supplementation on glyceroltrinitrate (GTN)-induced hemodynamic effects during 3-d nonintermittent transdermal administration of GTN (0.4 mg/h) in nine healthy subjects. Tolerance development was monitored by changes in arterial pressure, dicrotic digital pulse pressure, and heart rate. Studies with GTN, Vit-C, or GTN/Vit-C were successively carried out at random in three different series in the same subjects. GTN treatment caused an immediate rise in arterial conductivity (a/b ratio of dicrotic pulse), but within 2 d of initiating GTN, the a/b ratio progressively decreased and reached basal levels. In addition, there was a progressive loss of the orthostatic decrease in blood pressure. However, coadministration of Vit-C and GTN fully maintained the GTN-induced changes in the orthostatic blood pressure, and the rise of a/b ratio was augmented by 310% for the duration of the test period. Changes in vascular tolerance in GTN-treated subjects were paralleled by upregulation of the activity of isolated platelets, which was also reversed by Vit-C administration. These findings demonstrate that dietary supplementation with Vit-C eliminates vascular tolerance and concomitant upregulation of ex vivo-washed platelet activity during long-term nonintermittent administration of GTN in humans.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
Application of nitric oxide in drug discovery and development
Nathan S Bryan |
Expert Opin Drug Disc |
2011 |
.
|
Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species
Andreas Daiber |
Biochim Biophys Acta Bioenerg |
2010 |
.
|
The effect of nitroglycerin tolerance on oxidative stress and anaerobic sulfur metabolism in rat tissues
Magdalena Dudek, Anna Bilska, Marek Bednarski, MaÅgorzata Iciek, Inga KwiecieÅ, Maria SokoÅowska-Jeżewicz, Barbara Filipek, Lidia WÅodek |
Fundamental & Clinical Pharmacology |
2010 |
.
|
Different effects of ascorbate deprivation and classical vascular nitrate tolerance on aldehyde dehydrogenase-catalysed bioactivation of nitroglycerin
MV Wenzl, G Wölkart, H Stessel, M Beretta, K Schmidt, B Mayer |
British Journal of Pharmacology |
2009 |
.
|
The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles
B Mayer, M Beretta |
British Journal of Pharmacology |
2009 |
.
|
Goran Bjelakovic, Dimitrinka Nikolova, Lise Lotte Gluud, Rosa G Simonetti, Christian Gluud, Goran Bjelakovic |
Cochrane Database of Systematic Reviews |
2008 |
.
|
Nitric Oxide Donors
Tadahiko Yamamoto, Richard J. Bing |
Proceedings of the Society for Experimental Biology and Medicine |
2008 |
.
|
Vascular tolerance to nitroglycerin in ascorbate deficiency
G. Wolkart, M. V. Wenzl, M. Beretta, H. Stessel, K. Schmidt, B. Mayer |
cardiovas res |
2008 |
.
|
Targeting Nitric Oxide With Drug Therapy
R. Preston Mason, Jhon R. Cockcroft |
The Journal of Clinical Hypertension |
2006 |
.
|
Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance
Karsten Sydow, Andreas Daiber, Matthias Oelze, Zhiqiang Chen, Michael August, Maria Wendt, Volker Ullrich, Alexander Mülsch, Eberhard Schulz, John F. Keaney, Jonathan S. Stamler, Thomas Münzel |
Journal Clinical Investigation |
2004 |
.
|
Nitrate tolerance, oxidative stress, and mitochondrial function: another worrisome chapter on the effects of organic nitrates
John D. Parker |
Journal Clinical Investigation |
2004 |
.
|
Nitrate tolerance and the links with endothelial dysfunction and oxidative stress
Katherine E. Fayers, Michael H. Cummings, Kenneth M. Shaw, David W. Laight |
British Journal of Clinical Pharmacology |
2003 |
.
|
Melatonin inhibits nitrate tolerance in isolated coronary arteries
Stephen T O'Rourke, Hana Hammad, Philippe Delagrange, Elizabeth Scalbert, Paul M Vanhoutte |
British Journal of Pharmacology |
2003 |
.
|
Organic nitrate-induced oxidant stress and cardiovascular therapy
David W Laight |
eotp |
2003 |
.
|
Roland Keimer, Friederike Stutzer, Dimitrios Tsikas, Raphael Troost, Frank-Mathias Gutzki, Jurgen Frolich |
J Cardiovasc Pharmac |
2003 |
.
|
Nitric oxide releasing drugs: from bench to bedside
G Cirino |
DIG LIVER DIS |
2003 |
.
|
Interactions of Homocysteine, Nitric Oxide, Folate and Radicals in the Progressively Damaged Endothelium
Olaf Stanger, Martin Weger |
cclm |
2003 |
.
|
ST-segment elevation myocardial infarction
Yerem Yeghiazarians, Peter H. Stone |
Curr Treat Options Cardiovasc Med |
2002 |
.
|
Mechanisms of nitric oxide generation from nitroglycerin and endogenous sources during hypoxiain vivo
Per Agvald, L Christofer Adding, Andreas Artlich, Magnus G Persson, Lars E Gustafsson |
British Journal of Pharmacology |
2002 |
.
|
Early vascular abnormalities and de novo nitrate tolerance in diabetes mellitus
G. E. McVeigh, D. R. Morgan, P. Allen, M. Trimble, P. Hamilton, L. J. Dixon, B. Silke, J. R. Hayes |
Diabetes Obes Metab |
2002 |
.
|
|
|
|